Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...
Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...
In March 2024, the FDA approved the first over-the-counter continuous glucose monitors (CGMs), marking a quiet but significant shift in how we can track and understand our health. Devices like ...
Editor's note: This article has been updated with clarifying comments from Dexcom. Glucose-monitoring specialist Dexcom made several announcements this year, including receiving FDA clearance for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results